Prevalence of metabolic dysfunction associated fatty liver disease in people with type 1 diabetes

被引：0
|
作者：
Bellido, V. [1 ]
Amuedo, S. [1 ]
Remon-Ruiz, P. [1 ]
Roque-Cuellar, C. [1 ]
Jimenez-Sanchez, A. [1 ]
Gros-Herguido, N. [1 ]
Lopez-Gallardo, G. [1 ]
Pinar-Gutierrez, A. [1 ]
Soto-Moreno, A. [1 ]
机构：
[1] Hosp Univ Virgen Rocio, UGC Endocrinol & Nutr, Seville, Spain
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：S498 / S499
页数：2
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes
    Snaith, Jennifer R.
    Danta, Mark
    Greenfield, Jerry R.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 985 - 986
  • [2] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [3] Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes
    Snethlage, Coco M. Fuhri
    Meijnikman, Abraham S.
    Mak, Anne Linde
    Rampanelli, Elena
    Voermans, Bas
    Callender, Cengiz A. K.
    de Groen, Pleun
    Roep, Bart O.
    van Raalte, Daniel H.
    Knop, Filip K.
    Holleboom, Adriaan G.
    Nieuwdorp, Max
    Hanssen, Nordin M. J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 190 (05) : 391 - 400
  • [4] Impact of Metabolic Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease on Cardiovascular Risk in People with and without Type 2 Diabetes
    Matsubayashi, Yasuhiro
    Fujihara, Kazuya
    Yamada, Mayuko H.
    Yaguchi, Yuta
    Yamamoto, Masahiko
    Ishiguro, Hajime
    Kitazawa, Masaru
    Iwanaga, Midori
    Yamada, Takaho
    Kodama, Satoru
    Sone, Hirohito
    DIABETES, 2022, 71
  • [5] Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes
    Della Pepa, G.
    Lupoli, R.
    Masulli, M.
    Boccia, R.
    De Angelis, R.
    Gianfrancesco, S.
    Piccolo, R.
    Rainone, C.
    Rivellese, A. A.
    Annuzzi, G.
    Bozzetto, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (09) : 2371 - 2378
  • [6] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [7] Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes
    Qu, Huanjia
    Zhou, Lingling
    Wang, Jing
    Tang, Dong
    Zhang, Qiuling
    Shi, Junping
    OBESITY, 2025, 33 (03) : 490 - 499
  • [8] A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
    Efrem, Ion Cristian
    Mota, Maria
    Vladu, Ionela Mihaela
    Mitrea, Adina
    Clenciu, Diana
    Timofticiuc, Diana Cristina Protasiewicz
    Diaconu, Ileana-Diana
    Turcu, Adina
    Crisan, Anda Elena
    Geormaneanu, Cristiana
    Glodeanu, Adina Dorina
    Mahler, Beatrice
    Tudor, Marinela Sinziana
    Amzolini, Anca Maria
    Micu, Simona Elena
    Abu Alhija, Anca Barau
    Mita, Adrian
    Filip, Maria Monalisa
    Fortofoiu, Maria
    DIAGNOSTICS, 2022, 12 (10)
  • [9] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Maurice Michel
    Christian Labenz
    Angelo Armandi
    Leonard Kaps
    Wolfgang Maximilian Kremer
    Peter R. Galle
    Daniel Grimm
    Martin Sprinzl
    Jörn M. Schattenberg
    Scientific Reports, 13
  • [10] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345